Browsing by Author MORGENSTERN ALFRED

Showing results 21 to 40 of 117 < previous   next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2017JRC106150Biodistribution, dosimetry and imaging of 225Ac-DOTA-anti-PD-L1-BC in a murine immunocompetent transgenic breast cancer modelJOSEFSSON ANDERS; NEDROW JESSIE; PARK SUNJU; BAECK TOM; HOBBS ROBERT F.; BRAYTON CORY; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.Articles in periodicals and books
2007JRC37152Breaking Chemo- and Radioresistance with [Bi-213]anti-CD45 Antibodies in Leukemia CellsFRIESEN C.; GLATTING G.; KOOP B.; SCHWARZ K.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; DEBATIN K.m.; RESKE S.n.Articles in periodicals and books
2019JRC116460Combining Bismuth-213 with Nanobodies: finding the perfect match for Targeted Alpha TherapyDEKEMPENEER YANA; CAVELIERS VICKY; D'HUYVETTER MATTHIAS; MAERTENS DOMINIC; GYSEMANS M.; OOMS MAARTEN; LAHOUTTE TONY; XAVIER CATHARINA; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED, et alArticles in periodicals and books
2006JRC35134Control of Prostate Cancer Spheroid Growth Using (213)Bi-labeled Multiple Targeted Alpha RadioimmunoconjugatesWANG J.; RIZVI S.m.a.; MADIGAN C.; COZZI P.j.; POWER C.a.; QU C.f.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; RUSSEL P.j.; ALLEN B.j., et alArticles in periodicals and books
2019JRC116618Correlation between PSA response and response assessment with 68Ga-PSMA-11 PET/CT-derived metabolic parameters in patients treated with 225Ac-PSMA-617 for metastatic prostate carcinomaLAWAL I; MORGENSTERN ALFRED; KNOESEN OTTO; VORSTER MARIZA; POPOOLA GO; MAHAPANE JOHNCY; LENGANA T; BOSHOMANE T; MOKOALA K; BRUCHERTSEIFER FRANK, et alArticles in periodicals and books
2017JRC106151Correspondence between alpha-particle emitter dosimetry and normal organ toxicityJOSEFSSON ANDERS; NEDROW JESSIE; HOBBS ROBERT F.; BAECK TOM; PARK SUNJU; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS GEORGEArticles in periodicals and books
2005JRC30447Cyclotron Production of Ac-225 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; MOELLENBECK J.; MORGENSTERN ALFRED; ABBAS KAMELArticles in periodicals and books
2005JRC32186Cyclotron Production of Ac-225 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; ABBAS KAMEL; MOELLENBECK J.; MORGENSTERN ALFREDArticles in periodicals and books
2008JRC44968The Cytokinesis-Block Micronucleus Assay as a Biological Dosimeter for Targeted Alpha TherapySONG E.; RIZVI S.; QU C. F.; RAJA C.; YUEN J.; LI Y.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J.Articles in periodicals and books
2006JRC33597Cytotoxicity of PAI2, C595 and Herceptin Vectors Labeled with the Alpha-Emitting Radioisotope Bismuth-213 for Ovarian Cancer Cell Monolayers and ClustersSONG Y.j.; QU C.f.; RIZVI S.m.a.; LI Y.; ROBERTSON G.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; PERKINS A.c.; ALLEN Barry J.Articles in periodicals and books
2019JRC112445Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?DOS SANTOS JOSE CARLOS; SCHAEFER MARTIN; BAUDER-WÜST ULRIKE; LEHNERT WENCKE; LEOTTA KARIN; MORGENSTERN ALFRED; KOPKA KLAUS; HABERKORN UWE; MIER WALTER; KRATOCHWIL CLEMENSArticles in periodicals and books
2019JRC113789Development and dosimetry of Pb-203 / Pb-212 labeled PSMA ligands – Bringing “the Lead” into PSMA-Targeting Alpha Therapy?KRATOCHWIL CLEMENS; DOS SANTOS JOSE CARLOS; LEHNERT WENCKE; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; HABERKORN UWE; KOPKA KLAUS; MIER WALTERArticles in periodicals and books
2008JRC44967Development and Evaluation of Peptidic Ligands Targeting Tumor-associated Urokinase Plasminogen Activator Receptor (uPAR) for Use in Alpha-emitter Therapy of Disseminated Ovarian CancerKNOER S.; SATO S.; HUBER T.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHMITT M.; KESSLER H.; SENEKOWITSCH-SCHMIDTKE R.; MAGDOLEN V.; SEIDL C.Articles in periodicals and books
2019JRC120174Development of Targeted Alpha Therapy from Bench to BedsideMORGENSTERN ALFRED; BRUCHERTSEIFER FRANKArticles in periodicals and books
2019JRC113165DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assaySCHMEISER HEINZ; MUEHLBAUER KARL-RUDOLPH; MIER WALTER; BARANSKI ANN-CHRISTIN; NEELS OLIVER; DIMITRAKOPOULOU-STRAUSS ANTONIA; SCHMEZER PETER; KRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED, et alArticles in periodicals and books
2019JRC113164Drugs that modify cholesterol metabolism alter the p38/JNK-mediated targeted and nontargeted response to alpha and Auger radioimmunotherapyLADJOHOUNLOU RIAD; LOZZA CATHERINE; PICHARD ALEXANDRE; CONSTANZO JULIE; KARAM JIHAD; LE FUR PIERRE; DESHAYES EMMANUEL; BOUDOUSQ VINCENT; PAILLAS SALOME; BUSSON MURIEL, et alArticles in periodicals and books
2018JRC106081Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in RadiotherapyWURZER A; SEIDL C.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHWAIGER MARKUS; WESTER HANS-JÜRGEN; NOTNI JOHANNESArticles in periodicals and books
2018JRC112882Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: Towards improved alpha-therapeuticsŠIMEČEK JAKUB; HERMANN PETR; SEIDL C.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; WESTER HANS-JÜRGEN; NOTNI JOHANNESArticles in periodicals and books
2018JRC111783Enhancing Targeted α-therapy for treatment of metastatic breast cancerNEDROW JESSIE; MCCARTY GREG; JOSEFSSON ANDERS; RAY SANGEETA; CORTEZ ANGEL; SONG HONG; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.Articles in periodicals and books
2018JRC107697Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α‑Particle Therapy of CancerPRUSZYNSKI MAREK; D'HUYVETTER MATTHIAS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; LAHOUTTE TONYArticles in periodicals and books